Fibronectin is a large glycoprotein that circulates in blood and sits within tissues as a dimer, meaning two nearly identical protein chains linked at their tails by disulfide bonds. Each chain is built from a repeating series of compact structural modules, and the whole molecule can shift between a tightly coiled shape and an extended strand depending on its environment. That combination of modular architecture, obligate dimerization, and shape-shifting flexibility makes fibronectin one of the more structurally interesting molecules in the extracellular matrix, and it explains why the protein can interact with so many different partners.
The Three Types of Repeating Modules
Each fibronectin subunit is roughly 2,500 amino acids long, and almost all of that length is accounted for by three types of small, independently folding units arranged in a specific order along the chain. These are called type I, type II, and type III repeats. There are 12 type I modules, 2 type II modules, and 15 to 17 type III modules per subunit, depending on splicing. Analysis of the fibronectin gene shows that individual exons correspond precisely to these repeating structural units, and that alternative use of certain exons produces subunit variants that differ by the presence or absence of specific modules.1PubMed Central. Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation
Type I repeats are the smallest, stabilized by internal disulfide bonds. They cluster near the beginning and end of each subunit and are responsible for binding to fibrin, to other fibronectin molecules, and to bacterial surface proteins. Type II repeats appear only in a short stretch within the collagen-binding region and also contain disulfide bonds. Type III repeats are the most numerous and arguably the most functionally interesting. They lack disulfide bonds entirely, which means they can unfold under mechanical force without needing a chemical bond to break first. That property turns out to be central to how the protein behaves in living tissue.
How the Dimer Forms
Fibronectin is secreted from cells exclusively as a dimer. The two subunits are connected by a pair of disulfide bonds located near their C-terminal ends.2PubMed Central. Dynamic Structure of Plasma Fibronectin This linkage happens inside the cell before the protein is released, so soluble fibronectin in the bloodstream and fibronectin deposited into the extracellular matrix are both dimeric from the start. The dimerization is not optional; it is required for the protein to function properly. Much of what fibronectin does, from assembling into fibers to bridging cells to their surroundings, depends on having two arms that can each engage binding partners independently while remaining tethered together.
Each subunit contains three types of repeating modules, and the integrins that cells use to grab onto fibronectin recognize a short peptide sequence called RGD located on the tenth type III repeat.3PubMed Central. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly Having two copies of that sequence per dimer, one on each arm, helps the molecule serve as an effective bridge between cell-surface receptors and the surrounding matrix.
Compact or Extended, Depending on Conditions
One of the more striking features of fibronectin is that its overall shape is not fixed. In the bloodstream, where ionic strength is relatively high, each subunit extends into a long, flexible strand. At lower ionic strength, the same molecule curls into a more compact, irregularly coiled form. This has been measured directly: intact fibronectin sediments at about 13.5 S in low-salt conditions (compact) and 10 S in higher-salt conditions (extended), and isolated half-molecules show a similar shift, sedimenting at 11.5 S and 7.5 S, respectively.4Journal of Biological Chemistry. Ionic strength-dependent conformation changes of fibronectin. Studies on intact molecules, half-molecules, and proteolytic fragments
The fact that half-molecules change shape on their own tells us something important: the conformational shift is not driven by the two arms of the dimer pulling on each other. Instead, it happens through short-range electrostatic interactions along each strand. In other words, charged patches on nearby modules attract or repel each other depending on the salt concentration, causing the chain to fold up or stretch out. Electron microscopy confirms the picture, showing extended strands at physiological salt and irregularly coiled structures at low salt.
In the body, this conformational flexibility matters because fibronectin encounters different environments. Soluble fibronectin in plasma circulates in a relatively compact form that keeps many of its binding sites tucked away. When the protein reaches a wound site or is pulled on by cells, those hidden sites become accessible, a theme that runs through nearly every aspect of the molecule’s biology.
What Happens When You Pull on a Type III Module
Because type III repeats lack disulfide bonds, mechanical force can unfold them without breaking any covalent bonds. Researchers have used atomic force microscopy to stretch individual fibronectin type III modules and watch what happens. When the tenth type III repeat is pulled, it does not snap open all at once. Instead, it unfolds in two steps. The native structure first gives way at about 100 piconewtons of force, extending the module by roughly 12 nanometers and reaching a clearly defined intermediate. That intermediate then unfolds at a lower force, around 50 piconewtons, adding another 19 nanometers of length.5PubMed. Mechanical unfolding intermediates observed by single-molecule force spectroscopy in a fibronectin type III module
Molecular dynamics simulations have mapped out these unfolding pathways in detail. The simulations show that up to three intermediate states can appear as the module is stretched, corresponding to progressive separation of specific pairs of beta-strands within the folded structure.6Journal of Molecular Biology. Identifying Unfolding Intermediates of FN-III10 by Steered Molecular Dynamics There are at least two distinct pathways by which the unfolding can proceed. In one, the A and B strands peel away from the body of the module first; in the other, the G strand detaches first. Site-directed mutations in the A-B region or near the end of the G strand can shift the module between these pathways, demonstrating that the unfolding route depends on local structural details.5PubMed. Mechanical unfolding intermediates observed by single-molecule force spectroscopy in a fibronectin type III module
When two adjacent type III modules are connected, simulations show that one domain unfolds completely before the other begins to open.7PubMed. Forced unfolding of fibronectin type 3 modules: an analysis by biased molecular dynamics simulations This sequential behavior means that fibronectin does not simply fall apart under tension. It extends gradually, one module at a time, like pulling beads off a string one by one rather than cutting the string in half.
Cryptic Binding Sites and the Stretch-Activation Principle
The stepwise unfolding of type III modules is not just a biophysical curiosity. It has direct biological consequences. Many of the binding sites that fibronectin uses to interact with other molecules are buried inside folded type III repeats and only become accessible when those repeats partially unfold. These are called cryptic sites, and their exposure is a graded response: the more fibronectin fibers are stretched, the more cryptic sites open up, which in turn increases fiber rigidity and changes how nearby cells behave.8PubMed Central. Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites
The first type III repeat is a key example. When it partially unfolds under mechanical tension, it exposes binding sites that promote fibronectin molecules to stick to each other, a process essential for building the protein into fibers. Structural modeling suggests that the partially unfolded intermediate of this repeat is the form that actually drives fiber assembly.9PubMed Central. Structure and functional significance of mechanically unfolded fibronectin type III intermediates In this way, the protein uses mechanical force as a biological signal: cells pull on fibronectin, the molecule partially unfolds, hidden sites appear, and new interactions form. The result is a matrix that stiffens and remodels itself in response to the very forces that cells apply to it.
From Soluble Dimer to Insoluble Fiber
Fibronectin in the bloodstream is soluble and does not spontaneously form fibers. Fiber assembly, called fibrillogenesis, requires cells. The process starts when integrins on a cell surface bind to the RGD site on fibronectin dimers. That receptor binding triggers two things: it begins to unravel the compact conformation of fibronectin, exposing fibronectin-to-fibronectin binding sites, and it activates the cell’s internal actin-based contractile machinery to generate the pulling forces needed to continue stretching the molecule.10PubMed. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process
The N-terminal type I repeats play a critical role here. They contain the primary self-association domain, the stretch of the molecule responsible for linking one fibronectin dimer to the next. As conformational changes expose additional binding sites along the molecule, fibronectin dimers begin to stack together into thin fibrils, which then bundle and mature into thicker, insoluble fibers that become a permanent part of the extracellular matrix.11PubMed Central. Assembly of fibronectin extracellular matrix The conversion from soluble to insoluble is essentially irreversible under normal conditions, which gives the assembled matrix long-term stability.
The Collagen-Binding Region
A stretch of modules in the middle of each fibronectin subunit, spanning type I and type II repeats, forms the gelatin-binding domain. This is the region that lets fibronectin stick to collagen and, by extension, integrate itself into connective tissue. Crystallographic analysis shows that the modules in this domain pack together into a compact, globular unit through extensive interdomain contacts, rather than simply dangling from each other like beads on a chain.12PubMed Central. Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI
The collagen peptide that fits into this region adopts a strand-like shape that runs antiparallel to the fibronectin domain, and the specific collagen sequence recognized sits adjacent to the site where matrix metalloproteinases cut collagen.13PubMed Central. Identification and structural analysis of type I collagen sites in complex with fibronectin fragments That proximity is probably not a coincidence: it means that when collagenases begin degrading collagen during tissue remodeling or wound healing, the newly exposed collagen ends are exactly the kind of surface fibronectin likes to grip. Zinc ions can also affect this region, inducing structural rearrangement of the gelatin-binding domain that alters its collagen-binding behavior.14Structure. Zinc Induces Structural Reorganization of Gelatin Binding Domain from Human Fibronectin and Affects Collagen Binding
The Heparin-Binding Region
Fibronectin also binds to heparin and heparan sulfate, sugar-based molecules found on cell surfaces and in the matrix. The primary heparin-binding site sits on type III repeats 12 through 14, with the dominant interaction concentrated on a cluster of positively charged residues in repeat 13. When those positively charged amino acids are mutated to uncharged residues, heparin binding drops by about 98%.15Journal of Biological Chemistry. Localization of the major heparin-binding site in fibronectin Crystal structures confirm the picture: repeat 13 hosts the primary site, while a secondary site sits roughly 60 angstroms away on repeat 14.16PubMed Central. Crystal structure of a heparin- and integrin-binding segment of human fibronectin
NMR spectroscopy has further dissected the synergy between these two repeats. Repeat 14 on its own binds heparin fragments with similar affinity to repeat 13 alone, but when the two repeats are connected by their natural linker sequence, the binding behavior changes: heparin perturbation of repeat 14 decreases, indicating that the main heparin-binding site in the intact protein is primarily on repeat 13, with repeat 14 playing a supporting role.17PubMed. The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site Heparin binding helps fibronectin co-localize with growth factors and cell-surface proteoglycans, making this region a hub for signaling interactions in the matrix.
Splice Variants and Oncofetal Isoforms
There is only one fibronectin gene in the human genome, but alternative splicing of its messenger RNA can produce roughly 20 different protein variants. The splicing occurs at three specific sites, which control whether three extra domains are included or skipped: EDA, EDB, and a connecting segment called IIICS. The EDA and EDB domains are type III repeats that get inserted between their neighbors when their exons are included.18PubMed. Fibronectin-targeted drug delivery in cancer
What makes these variants clinically interesting is their expression pattern. EDA- and EDB-containing fibronectin isoforms are abundant during embryonic development but largely absent in healthy adult tissues. They reappear in tumors, which is why they are called oncofetal isoforms. This reappearance has made them attractive targets for drug delivery: if you can attach a therapeutic agent to an antibody or peptide that recognizes EDB-fibronectin, you have a way to concentrate drugs at tumor sites while sparing normal tissue.18PubMed. Fibronectin-targeted drug delivery in cancer
How Glycosylation Tweaks the Structure
Fibronectin is a glycoprotein, meaning sugar chains are attached at multiple sites along its length. These are primarily asparagine-linked (N-linked) oligosaccharides. Removing the sugars experimentally doesn’t destroy the protein, but it changes its behavior in revealing ways. Deglycosylated fibronectin binds more strongly to gelatin and promotes cell adhesion and spreading more effectively than the glycosylated form, while heparin binding stays unchanged.19PubMed Central. Fibronectin glycosylation modulates fibroblast adhesion and spreading The structural solution of a glycosylated type II module suggests that the sugar chains may also contribute to protein stability and resistance to degradation by proteases.20Journal of Molecular Biology. Solution structure of the glycosylated second type 2 module of fibronectin
The emerging picture is that glycosylation acts as a tuning mechanism. The sugars partially shield certain interaction surfaces, dialing down binding activities that might otherwise be too strong. In a protein with as many binding partners as fibronectin has, that kind of modulation is probably essential for keeping everything in balance.
When Tumors Remodel Fibronectin
The tumor microenvironment is a mechanically abnormal place. Stromal cells called myofibroblasts generate strong contractile forces that stretch and remodel the extracellular matrix. Because fibronectin’s type III domains can unfold under tension, this results in a population of fibronectin molecules in the tumor stroma that are chronically stretched and partially unfolded. Research has shown that the partially unfolded first type III domain of fibronectin activates an inflammatory signaling pathway in lung cancer cells, triggering production of the pro-inflammatory molecule IL-8 through a toll-like receptor pathway.21PubMed Central. Fibronectin in the Tumor Microenvironment Activates a TLR4-dependent Inflammatory Response in Lung Cancer Cells
This is a case where the structural properties of fibronectin feed directly into disease biology. The same conformational flexibility that allows the protein to expose cryptic sites for normal tissue assembly can, in the wrong context, generate danger signals that fuel chronic inflammation and tumor progression. The structure is not just a scaffold; it encodes information that cells read differently depending on its mechanical state.
Bacteria That Exploit Fibronectin’s Architecture
Fibronectin sits at the interface between cells and their surroundings, which makes it a natural target for bacterial pathogens looking for a way in. Many species of bacteria, particularly Gram-positive ones, produce surface proteins that specifically recognize and bind fibronectin. These fibronectin-binding proteins allow bacteria to hitch a ride on the host’s own adhesion machinery, facilitating attachment to host cells and in some cases active invasion.22PubMed Central. Stuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive Bacteria
The bacterial proteins typically target the N-terminal type I repeats of fibronectin. Structural studies of collagen peptides bound to fibronectin have revealed that the collagen peptide adopts a conformation strikingly similar to that of bacterial proteins bound to the same type I domains.13PubMed Central. Identification and structural analysis of type I collagen sites in complex with fibronectin fragments In other words, the bacteria appear to have evolved surface proteins that mimic how the host’s own matrix molecules interact with fibronectin, co-opting a binding mode that the protein was already built to accept.
Engineering with Fibronectin Fibers
The structural properties of fibronectin have attracted interest from bioengineers trying to build three-dimensional tissue scaffolds. One approach uses hydrodynamic forces to induce fibronectin fibrillogenesis outside the cell, generating networks of fibrillar fibronectin supported by polymer scaffolds. These engineered networks are mechanically robust and promote cell invasion and proliferation, and they can induce an epithelial-to-mesenchymal transition in cancer cells, a behavior associated with increased migration and invasiveness.23PubMed Central. Engineered Fibrillar Fibronectin Networks as Three-Dimensional Tissue Scaffolds
The ability to trigger fibrillogenesis without living cells opens up possibilities for creating defined matrix environments for studying cancer biology, drug screening, and regenerative medicine. It also underscores how much of fibronectin’s behavior is encoded in its molecular structure rather than in any particular cellular signaling pathway. Give it the right physical conditions, and the protein assembles itself.
An Evolutionary Latecomer
Given how central fibronectin is to vertebrate wound healing, embryonic development, and tissue structure, you might assume it is an ancient molecule shared across the animal kingdom. It is not. Comparative genomics indicates that fibronectin first appeared in vertebrates. A predicted fibronectin with the same domain organization found in mammals exists in the sea lamprey, but nothing comparable has been identified in tunicates or other invertebrate chordates.24PubMed Central. The evolution of tenascins and fibronectin
The integrin-binding motifs within the molecule also have their own evolutionary timeline. The LDV-type motifs, which are recognized by certain integrins, are conserved across a broad range of vertebrate fibronectins. But the RGD motif that dominates integrin binding in mammals may have evolved later, possibly in jawed vertebrates. If that is correct, the earliest fibronectins relied on a different set of cell-surface interactions than the ones studied most intensively today, and the RGD-dependent biology was a relatively recent evolutionary addition layered on top of an older structural framework.